MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1. [electronic resource]
Producer: 20200925ISSN:- 1573-4935
- Antimetabolites, Antineoplastic -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Integrin beta1 -- genetics
- MicroRNAs -- genetics
- PC-3 Cells
- Pancreas -- diagnostic imaging
- Pancreatic Neoplasms -- drug therapy
- RNA Helicases -- genetics
- RNA, Messenger -- genetics
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.